Survodutide
An investigational dual agonist that hits both the GLP-1 and the glucagon receptor. People run it for appetite control and fat loss, with the glucagon arm adding a metabolic-rate and liver-fat angle that pure GLP-1 drugs do not have.
Where to buy Survodutide, cheapest first.
Prices from 2 vendors across the market. We link straight to each vendor’s product page and grade vendors on public lab data, so you’re not just chasing the lowest number.
What Survodutide actually does.
The simple version first, then a little more for the curious. No biochem degree required.
It turns down appetite like a GLP-1 drug, then adds a glucagon signal that nudges your body to burn more energy and clear fat from the liver, so the two effects stack.
How it works
Survodutide is a single peptide that activates two receptors at once. The GLP-1 side curbs appetite, slows gastric emptying, and helps regulate blood sugar. The glucagon side raises energy expenditure and pushes the liver to burn stored fat.
Where it acts
It works through the gut-brain appetite circuit and on the liver. It is deliberately biased toward GLP-1, with only partial glucagon activation, which is meant to add the metabolic boost without spiking blood sugar.
What people notice
Reduced appetite and steady weight loss over weeks to months, in the same range as the approved GLP-1 drugs. The effect builds slowly as the dose is titrated up, not overnight.
Honest caveat: the human data here comes from Boehringer Ingelheim's clinical trials, which is real and substantial, but Survodutide is still investigational and not approved anywhere. The vials sold by vendors are not the clinical product and are sold strictly for research use only. None of this is medical advice, talk to a licensed provider before starting anything.
How to take it.
Survodutide is a once-weekly subcutaneous injection, given into the fat with a tiny insulin needle. It is not an oral peptide, so the injectable form is what people run. The defining feature is slow titration; the routine is below, and the full schedule is in the guide.
Reconstitute the vial
Add bacteriostatic water down the side of the vial (a 10mg vial + 2mL = 5mg/mL). Let it dissolve. Swirl gently, don't shake.
Draw your dose
On a U-100 insulin syringe, pull to your unit mark. A 0.6mg starting dose at 5mg/mL is 12 units (0.12mL). Use the calculator if you're unsure.
Pinch and inject
Swab with alcohol, pinch a bit of fat, insert at 45–90°, push slowly. Subcutaneous into the belly is simplest. This is a weekly shot, not daily.
Rotate your sites
Move to a different spot each week so no area gets sore or lumpy. Store the vial in the fridge between doses and use within about four weeks.
The easiest spots are the belly (about 2 inches either side of the navel), the love handles, the front of the thigh, and the back of the upper arms. Rotate every injection.
Don't do the math, let the calculator do it.
This is Survodutide's typical setup, already worked out. Change any value and the draw updates instantly.
Typical Survodutide dose: starting around 0.6 mg once a week, titrated up slowly by roughly 0.6 mg every two weeks as tolerated, toward a target near 4.8 mg weekly over three to four months. The slow ramp is what keeps nausea manageable.
Cycling Survodutide.
Whether Survodutide is cycled at all, how long people run it, and the honest reasoning behind it.
Titrated up slowly, not cycled.
A cycle here is less about on-and-off and more about the climb. The standard pattern is a slow titration up to the target dose over three to four months, then a maintenance phase at the target dose. People run it continuously the way the trials did, rather than in short bursts.
Why titrate so slowly? Almost entirely for tolerability. The GLP-1 effect causes nausea, and that nausea is worst when the dose jumps. A gradual climb gives the body time to adapt while still reaching an effective dose within a few months.
- Hold each step for about two weeks before increasing, so your gut can adapt.
- Do not skip ahead to a higher dose to speed things up. That is the fastest way to severe nausea.
- If you stop, taper rather than quitting cold, and treat any return of appetite or weight as a conversation for a licensed provider.
Want the full picture, on and off periods, the washout, stacking, and keeping your results? Read how peptide cycling works →
What's actually in the vial.
For one of these vendors we link the per-batch certificate itself, and the purity below is read straight off it. The rest link to the vendor's general lab-results page. We don't run the labs ourselves and we don't show a purity number unless it's printed on a certificate we link, so you can open the document and check it against the batch yourself.
| Vendor | Purity (per COA) | Batch / report | Certificate |
|---|---|---|---|
| Umbrella Labs | 99.8% | ULP-49131 | View COA ↗ |
What people pair it with.
Survodutide is usually run on its own while titrating, but people pair it with compounds that cover the gaps a GLP-1/glucagon agonist leaves.
Weight loss & muscle
The idea is to lose fat on Survodutide while a GH-releasing pair supports lean mass and recovery during the calorie deficit. People run this to avoid losing muscle along with the fat.
View stack →Weight loss combo
Cagrilintide is an amylin analog that adds a separate satiety signal. Pairing it with a GLP-1/glucagon agonist is the dual-mechanism approach the next-gen weight research is exploring.
View stack →Healing alongside cut
Some people add BPC-157 for gut and soft-tissue support during an aggressive cut. It does not aid fat loss directly; it is there for recovery while in a deficit.
View stack →In the same corner.
Other weight and metabolic peptides people compare against Survodutide.
Questions, answered straight.
Is Survodutide legal?
Survodutide is an investigational drug. It is not approved for human use anywhere yet, and the vendors we compare offer it strictly for research use only. It is not currently named on WADA's prohibited list, but anti-doping bodies watch this class closely, so competing athletes should check current rules. Rules vary by country, so check what applies where you are.
What does research use only actually mean?
It means the product is sold for laboratory and research purposes, not as a supplement or medicine for people. It has not been reviewed or approved for human use by the FDA. We aggregate prices and public lab data so you can see the landscape; what you do with that is between you and a licensed provider.
How is it different from Semaglutide or Tirzepatide?
Semaglutide hits one receptor (GLP-1) and Tirzepatide hits two (GLP-1 and GIP). Survodutide hits GLP-1 plus glucagon. The glucagon arm is meant to raise energy expenditure and reduce liver fat, which is why it is also studied for liver disease (MASH), not just weight.
How do people dose it?
Once weekly, starting low (around 0.6 mg) and titrating up slowly over three to four months toward roughly 4.8 mg, because the slow ramp keeps nausea manageable. Use the calculator to turn your vial and dose into exact units on a U-100 syringe.
How do I store it?
Keep the sealed, freeze-dried vial cold and out of light. Once you mix it with bacteriostatic water, store it refrigerated and use it within about four weeks. Don't freeze a reconstituted vial.